The application window for the 2022 MRA for Gene Therapy in Hemophilia A Program is closed.
This special HTRS Mentored Research Award (MRA) for Gene Therapy in Hemophilia A Program will provide a grant for a qualified fellow or junior attending/junior faculty (MDs, DOs, MBBSs or the equivalent) pursuing clinical, translational, or basic science research projects in Gene Therapy in Hemophilia A under the guidance of an experienced mentor.
The goals of the overall HTRS MRA Program are to:
- Increase the number of skilled physician-scientists in the U.S. medical workforce dedicated to long-term research careers in benign hematology
- Support innovative research by pairing talented young physician-scientists with experienced mentors, many of whom are recognized leaders in U.S. clinical and/or basic science research in hemostasis and thrombosis
- Provide trainees and junior faculty an accessible “on-ramp” into the NIH research pipeline by funding initial research programs that can spark and support K-award applications
2022 HTRS MRA for Gene Therapy in Hemophilia A: Request for Proposals (RFP)
Revised Budget Form for this MRA - Updated 12.15.2021
All applications are submitted on the HTRS grant application site at https://htrs.smapply.org Applicants who have not applied for an HTRS awards on Survey Monkey Apply previously should click on "Register" and create a new account with an email and password. The site allows you to save your work and return to it later.
Questions? Please contact Jennifer Ziegler, Director, Award Programs & Career Development at [email protected]
2022 HTRS Mentored Research Award for Gene Therapy in Hemophilia A
Supported by an independent medical training grant from: